THE THERAPEUTIC CHALLENGE IN SYSTEMIC TREATMENT OF ADVANCED AND RECCURENT ENDOMETRIAL CANCER
More than 300 000 new cases of endometrial cancer (EC) are registered annually in the world. The prognosis for EC is determined by the stage of the disease. In Russia, stage III–IV EC is diagnosed in 16 % of patients, with the mortality rate in the first year of follow-up of 9.2 %. The management of...
Saved in:
Main Authors: | I. Y. Bazaeva, S. V. Khokhlova, A. A. Fedenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2018-03-01
|
Series: | Сибирский онкологический журнал |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/672 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expanding therapeutic opportunities for progressive uterine cancer: clinical experience
by: A. G. Kedrova, et al.
Published: (2022-05-01) -
Influence of immune targeted therapy on immune system parameters in patients with endometrial cancer
by: M. N. Stakheyeva, et al.
Published: (2025-05-01) -
COMBINED TREATMENT FOR EARLY-STAGE ENDOMETRIAL CANCER
by: V. N. Nechushkina, et al.
Published: (2016-02-01) -
Features of the course of pregnancy and childbirth after conservative treatment of initial atypical hyperplasia and endometrial cancer
by: A. V. Charkhifalakyan, et al.
Published: (2025-01-01) -
Lenvatinib and pembrolizumab in patients with advanced uterine cancer
by: A. G. Kedrova, et al.
Published: (2021-01-01)